Forward P/S Multiple: Dexcom (DXCM)

DexCom, Inc. - graphic logo of issuer DXCM

DexCom, Inc. is expanding its glucose monitoring ecosystem by integrating sensors into smartwatches and insulin pumps. The company outsources a portion of component manufacturing and cloud data management to third-party contractors. Stable cash flow from global sales fuels R&D development. The estimated forward P/S on the GURU.Markets chart illustrates valuation trends, where the value 5.20 serves as the baseline indicator for market expectations.

dexcom.com - DXCM Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Summary analytical data breakdowns for Dexcom CGM (DXCM)

- market price and analyst price targets:
Price Chart Dexcom|DXCM - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Dexcom CGM|DXCM - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Dexcom|DXCM - Accounting Capitalization|Market Capitalization to Book Value Ratio dexcom.com|DXCM - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital DexCom, Inc.|DXCM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital DexCom, Inc.|DXCM - Company Aggregate Debts|Debt to Book Capitalization Ratio Dexcom CGM|DXCM - Company Long-Term Debt|Company Current Liabilities Dexcom|Quick Ratio dexcom.com
- financial results and valuation multiples details:
DXCM - Company Net Income|Expected Profit DexCom, Inc.|DXCM - Market Cap to Net Income Ratio|Projected Price to Earnings Dexcom Corp|DXCM - PEG Multiple|EV/EBITDA Multiple Dexcom CGM|DXCM - Operating income before deduction of amortization|Earnings per share for the last twelve months Dexcom|DXCM - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months dexcom.com|DXCM - Net earnings per share growth this year|Earnings growth forecast for next year DexCom, Inc.
- sales and revenue indicators:
DXCM - Company Total Revenue|Company Projected Revenue Dexcom|DXCM - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Dexcom CGM
Fundamental company analysis:DXCM (Dexcom)
Product sample of Dexcom CGM

The forward P/S ratio measures the market value of DexCom, Inc. (DXCM) relative to expected revenue, reflecting the level of investor confidence in the business's growth potential. Analyzing the dynamics of this ratio allows for the separation of speculative bubbles from fundamental strengthening. By examining the forward price-to-sales ratio, one can assess the capitalization premium awarded to DexCom, Inc. (DXCM) for its status as a tech leader scaling its ecosystem through the integration of sensors into third-party insulin pumps.

Who DexCom, Inc. competes with

Price-to-Projected Revenue Ratio Penumbra PEN|NOVT - Forward Price-to-Revenue Multiple|Haemonetics Corp. - Forward P/S Multiple|Market Cap to Future Revenue Ratio Inspire Medical Systems Inc|PRCT: Forward P/S Multiple|Market Cap to Projected Revenue CNMD|PLSE (Pulse Biosciences) - Forward P/S Multiple|InMode Ltd (INMD) - Market Cap to Expected Sales Ratio|Forward P/S Multiple PMI|Forward Price-to-Revenue Multiple Surmodics Inc. SRDX|Forward P/S Multiple SENS (Senseonics Holdings)|Forward P/S Multiple neuropace.com NPCE|TCMD - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|OM (Outset) - Forward Price-to-Revenue Multiple|Electromed - Forward Price to Sales|LNSR (LENSAR, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio avitamedical.com RCEL|Price-to-Projected Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Projected Price to Revenue|EDAP TMS - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Market Cap to Projected Revenue PFSA|SSKN (STRATA Skin Sciences Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio glucotrack.com GCTK|Forward Price-to-Revenue Multiple NAOV (NanoVibronix)|Venus Concept Corporation - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis, Inc.)|AEMD - Forward Price-to-Revenue Multiple|ASXC - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Avinger Inc.|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple Cutera Inc|Forward Price-to-Revenue Multiple KNW|NARI: Forward Price to Sales|Forward P/S Multiple NVRO|Market Cap to Expected Sales Ratio reshapelifesciences.com|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK